Patents by Inventor Mon-Tarng Chen

Mon-Tarng Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING A CANCER ASSOCIATED WITH THE ACTIVATION OF GALECTIN-1
    Publication number: 20210137945
    Abstract: Provided herein is a method for the treatment and/or prophylaxis of a cancer associated with galectin-1. The method includes administering to a subject a pharmaceutical composition that mainly composed of ganoderic acid S (GAS) and ganoderic acid T (GAT). The method further includes administering to the subject another anti-cancer agent before, together with, or after the administration of the present pharmaceutical composition, so as to synergistically suppress the growth of the cancer.
    Type: Application
    Filed: November 13, 2019
    Publication date: May 13, 2021
    Applicant: TRINEO BIOTECHNOLOGY CO. LTD
    Inventors: Teng-Hai CHEN, Mon-Tarng CHEN, Chien-Yuan WANG, Cheng-Po HUANG, Su-Yu CHEN, Yi-Hsiu LIN, Ssu-Chia WANG, Chih-Yuan LIAO
  • Industrial scale process of cultivating mycelium
    Patent number: 9820443
    Abstract: Disclosed herein is an industrial scale process of cultivating cultivating Ganoderma lucidum mycelia. As high as 15 Kg dried Ganoderma lucidum mycelia may be produced from about 300 liters liquid culture every 30 days, and the resulting dried Ganoderma lucidum mycelia are rich in triterpenoids that include at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS).
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: November 21, 2017
    Assignee: DOUBLE CRANE BIOTECHNOLOGY CO. LTD.
    Inventors: Li-Ming Huang, Chih-Wei Chen, Mon-Tarng Chen, Yen-Chun Liu, Kuang-Dee Chen
  • INDUSTRIAL SCALE PROCESS OF CULTIVATING GANODERMA LUCIDUM MYCELIUM
    Publication number: 20160044872
    Abstract: Disclosed herein is an industrial scale process of cultivating cultivating Ganoderma lucidum mycelia. As high as 15 Kg dried Ganoderma lucidum mycelia may be produced from about 300 liters liquid culture every 30 days, and the resulting dried Ganoderma lucidum mycelia are rich in triterpenoids that include at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS).
    Type: Application
    Filed: August 9, 2013
    Publication date: February 18, 2016
    Inventors: Liu-Ming HUANG, Chih-Wei CHEN, Mon-Tarng CHEN, Yen-Chun LU, Kuang-Dee CHEN
  • Process for separating organogermanium compounds and inorganogermanium compounds from a germanium-containing pharmaceutical plant or its processed products
    Patent number: 5744138
    Abstract: The present invention provides a process for separating organogermanium and inorganogermanium compounds from a germanium-containing pharmaceutical plant or its processed products by applying the extract of a germanium-containing pharmaceutical plant or its processed products into a combination column including a cation exchange resin in the lower part of the column and an anion exchange resin in the upper part of the column, eluting the combination column with deionized water to obtain inorganogermanium solution, then with an alkaline solution to release the organogermanium compounds, and finally with deionized water to obtain organogermanium solution. The present invention also provides a process for determining the total germanium, organogermanium, inorganogermanium content of a germanium-containing pharmaceutical plant or its processed products by ICP-AES.
    Type: Grant
    Filed: December 6, 1996
    Date of Patent: April 28, 1998
    Assignee: Food Industry Research & Development Institute
    Inventor: Mon-Tarng Chen